![](/img/cover-not-exists.png)
Comparison of a standard BCG dose (81 MG) versus a three-fold reduced dose (27 MG) in high risk superficial bladder cancer (TIG3, TIS), A cueto prospective randomised study #95012
J. Martinez-Piñeiro, L. Martinez-Piñeiro, E. Solsona, R. Hernandez Rodriguez, J. Fernández Gómez, M. González Martin, J. Rodriguez Molina, A. Gimeno, N. Flores, S. Isorna, C. Pertusa, M. Rabadán, A. AVolume:
2
Year:
2003
Language:
english
DOI:
10.1016/s1569-9056(03)80754-6
File:
PDF, 220 KB
english, 2003